Corporate News 14-Oct-25
Thyrocare Technologies declares bonus issue of 2:1
At board meeting held on 14 October 2025
The Board of Thyrocare Technologies has approved issuance of bonus shares in the proportion of 2:1, i.e. 2 bonus equity shares of Rs 10 each for every 1 fully paid-up equity share held as on the record date. Also, the board has declared an interim dividend of INR 7 per equity share of the face value of Rs 10 each, pre-bonus issuance
Previous News
Thyrocare Technologies to table results
( Corporate News - 17-Jul-26 09:52 )
Thyrocare Technologies schedules board meeting
( Corporate News - 17-Jul-25 10:16 )
Thyrocare Technologies to declare Quarterly Results
( Corporate News - 21-Jan-26 11:22 )
Thyrocare Technologies consolidated net profit rises 22.05% in the March 2025 quarter
( Results - Announcements 23-Apr-25 17:48 )
Board of Thyrocare Technologies recommends Final Dividend
( Corporate News - 23-Apr-25 16:32 )
Benchmarks pare some losses; realty shares decline
( Market Commentary - Mid-Session 24-Apr-25 10:33 )
Thyrocare Tech rises as Q3 PAT jumps 29% YoY to Rs 19 cr
( Hot Pursuit - 24-Jan-25 10:03 )
Thyrocare Technologies Ltd leads losers in 'B' group
( Hot Pursuit - 07-Jan-25 14:45 )
Volumes spurt at Axis Bank Ltd counter
( Hot Pursuit - 17-Nov-21 11:00 )
Thyrocare Technologies to convene board meeting
( Corporate News - 07-May-24 17:23 )
Thyrocare Technologies
( Results - Analysis 10-May-21 17:37 )
Other Stories
TMPV and Stellantis India expand partnership for vehicle development
12-Oct-26 20:44
CreditAccess Grameen raises USD 175 million syndicated social loan facility
12-Oct-26 20:41
LTTS launches AI-Native EI Lab for Digital Manufacturing in Bengaluru
12-Oct-26 20:38
Karnataka Bank launches 'Trade Konnect' digital platform
12-Oct-26 20:32
Aequs signs supply agreement with Safran for landing gear components
12-Oct-26 20:27
Empower forays into Robotics and AI implementation and system integration
12-Oct-26 20:17
Indian Hotels Co signs 47 hotels in first half of FY27
12-Oct-26 20:15
Skipper appoints R. N. Nayak as Non-Executive Independent Director
12-Oct-26 20:11
Sai Life Sciences allots 54,500 equity shares under ESOP
12-Oct-26 19:43
Board of Nazara approves conversion of loan to subsidiaries
12-Oct-26 19:25
Back
Top